133 related articles for article (PubMed ID: 5606156)
1. [Preliminary report on the use of corpus luteum in the cancerology of the endometrium and breast].
Hakami T; Demers FX
Laval Med; 1967 May; 38(5):450-3. PubMed ID: 5606156
[No Abstract] [Full Text] [Related]
2. [Cancer of the corpus uteri].
Suzuki T
Nihon Gan Chiryo Gakkai Shi; 1973 Dec; 8(4):331-55. PubMed ID: 4361657
[No Abstract] [Full Text] [Related]
3. [Progestational hormones in the treatment of gynecologic cancers].
Soutoul JH; Lagabrielle V
Presse Med (1893); 1969 Feb; 77(7):247-9. PubMed ID: 5795418
[No Abstract] [Full Text] [Related]
4. [Favorable course in carcinoma patients due to additional phenothiazine therapy].
Eicke WJ
Med Klin; 1973 Jul; 68(30):1015-8. PubMed ID: 4725489
[No Abstract] [Full Text] [Related]
5. [Hormofort in the treatment of metastatic adenocarcinoma of corpus uteri].
Kaliński R; Wlodarski A
Wiad Lek; 1972 Oct; 25(20):1903-5. PubMed ID: 4643245
[No Abstract] [Full Text] [Related]
6. [The place of hormonotherapy in cancerology].
Cah Med; 1972 Apr; 13(5):392-4. PubMed ID: 5055116
[No Abstract] [Full Text] [Related]
7. Oral progestin therapy for metastatic adenocarcinoma of the endometrium.
Puckett TG; Merrill JA
J Okla State Med Assoc; 1967 Sep; 60(9):506-11. PubMed ID: 6076025
[No Abstract] [Full Text] [Related]
8. [Use of progestational hormones in the treatment of advanced stages of breast and gynaecologic carcinoma].
Guérin MT; Guérin RA
Sem Hop; 1969 Dec; 45(51):3241-3. PubMed ID: 4312573
[No Abstract] [Full Text] [Related]
9. [Use of a new synthetic progestative agent in high dosage (ethynodiol diacetate) in the treatment of advanced forms of adenocarcinoma of the corpus uteri (apropos of 2 illustrative cases)].
Luzuy M; Soutoul JH; Luzuy R
Chirurgie; 1970 Oct; 96(12):859-67. PubMed ID: 5502831
[No Abstract] [Full Text] [Related]
10. [Utilization of high-dose norethindrone in the treatment of some genital hormono-dependent cancers].
Sonkin R; Coudeyras M; Thévenet M
Gynecol Obstet (Paris); 1969; 68(4):355-72. PubMed ID: 5354375
[No Abstract] [Full Text] [Related]
11. Progestogens in the treatment of carcinoma of the endometrium.
Kennedy BJ
Surg Gynecol Obstet; 1968 Jul; 127(1):103-14. PubMed ID: 5657772
[No Abstract] [Full Text] [Related]
12. [Preliminary note on histologic changes induced by a new synthetic gestagen (19-nor-17-alpha-hydroxyprogesterone capronate) on adenocarcinoma of the endometrium].
Vecchione A; Ruozi Berretta L
Riv Anat Patol Oncol; 1968; 33():431-60. PubMed ID: 5760166
[No Abstract] [Full Text] [Related]
13. Progestins in the treatment of endometrial carcinoma.
Anderson DG
Surg Forum; 1965; 16():398-400. PubMed ID: 5835208
[No Abstract] [Full Text] [Related]
14. Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features.
Barakat RR; Wong G; Curtin JP; Vlamis V; Hoskins WJ
Gynecol Oncol; 1994 Nov; 55(2):164-8. PubMed ID: 7959278
[TBL] [Abstract][Full Text] [Related]
15. [Clinical results of combination therapy with 32 Phosphorus and anabolics agents in multiple bone metastasis].
Kleibel F
Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:66-7. PubMed ID: 4341233
[No Abstract] [Full Text] [Related]
16. [Effect of oral gestagen on uterus carcinoma and on lung metastases following cervix- and breast carcinoma].
Bayer R
Wien Med Wochenschr; 1966 Oct; 116(41):831-5. PubMed ID: 5954296
[No Abstract] [Full Text] [Related]
17. Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study.
Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG; Rivkin SE
Cancer Treat Rep; 1985 Nov; 69(11):1329-30. PubMed ID: 4092197
[No Abstract] [Full Text] [Related]
18. [Clinical studies of a new corpus luteum steroid].
Lange-Sundermann K
Arzneimittelforschung; 1969 Aug; 19(8):1273-7. PubMed ID: 5820292
[No Abstract] [Full Text] [Related]
19. [Use of 17-alpha-hydroxprogesterone-capronate in certain malignant tumors].
Garin AM; Voznyĭ EK; Borisov VI; Dobrushina VA; Lazovskaia EB
Klin Med (Mosk); 1974 Mar; 52(3):121-3. PubMed ID: 4466932
[No Abstract] [Full Text] [Related]
20. [Medroxyprogesterone and endometrial adenocarcinoma].
Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
